News & Events

Switched-on Salmonella: fluid forces guide disease traits of multidrug resistant bacteria

June 8, 2016

Once inside the human body, infectious microbes like Salmonella face a fluid situation. They live in a watery world, surrounded by liquid continually flowing over and abrading their cell surfaces—a property known as fluid shear. In new research appearing in the Nature Publishing Group journal npj Microgravity, Cheryl Nickerson, Ph.D.,  and her colleagues explore the effects of physiological fluid shear on ST313—a particularly dangerous type of Salmonella, which is resistant to...

Superbug: What you need to know

June 1, 2016

ASU researcher explains how realistic all those "end of the world" headlines are Last week the Department of Defense issued a report detailing the case of a 49-year-old Pennsylvania woman who had a rare E. coli infection resistant to all antibiotics, including colistin, which is a harsh drug used only on the sickest patients. The superbug is the first known case of its kind in the United States, and the report sparked strong reactions. The concern was that traits of the infection could...

Student Spotlight: Breanne McCarthy

May 13, 2016

Breanne McCarthy’s undergraduate experience was out of this world - literally.  During her first year at ASU, McCarthy found an opportunity to work in astrobiology in Cheryl Nickerson’s lab at the Biodesign Institute.  “My first study with Dr. Nickerson’s lab was really cool because we were studying...how the spaceflight environment will change bacterial resistance or susceptibility to antibiotics,” said McCarthy, “I actually got to lead a teleconference with our...

Biomedicine and Biotechnology

April 13, 2016

Stephen Johnston, Ph.D., Professor and Co-director, Biodesign Center for Innovations in Medicine; Hugh Mason, Ph.D., Associate Professor, Biodesign Center for Infectious Diseases and Vaccinology; and Carlo Maley, Ph.D., Associate Professor, Virginia G. Piper Biodesign Center for Personalized Diagnostics. The ASU School of Life Sciences is presenting this seminar.  

Inventive ASU faculty recognized for record-breaking year

March 10, 2016

Arizona Technology Enterprises (AzTE) recently celebrated a record-breaking year for the number of inventions, patents and startup companies that have come out of Arizona State University. “The purpose of this event is really to thank ASU’s inventive faculty for their innovation, creativity and hard work,” said Ken Polasko, the executive director at AzTE, ASU’s exclusive intellectual property management and technology transfer organization. During fiscal year 2015, ASU faculty...

Arntzen honored as inaugural 'Rodale 100' recipient

February 2, 2016

Rodale, Inc., a highly influential publisher of some of the most established health and wellness lifestyle brands including Prevention, Men's Health, Women's Health, and Runner's World, has honored ASU Regents' professor Charles Arntzen with its highest honor. Arntzen has been named to the inaugural Rodale 100 list, which celebrates those who share the Rodale, Inc. mission: to inspire health, healing, happiness and love in the world.  Charles...

ASU's Dr. Qiang Chen on what to expect from the latest global health concern

January 29, 2016

The World Health Organization warned Thursday that the Zika virus is “spreading explosively” in the Americas, and countries and health organizations are on full alert with emergency meetings taking place to prepare to halt the spread of the Zika virus. WHO officials estimate that 1 million people are already infected in South America, and 4 million to 5 million more could be infected in 2016, as temperatures warm in the Northern Hemisphere. About 51 people in the U.S. are currently...

PCocSH: A Plant-produced Human Butyrylcholinesterase Variant for Treatment of Cocaine Addiction-related Diseases

January 28, 2016

Tsafrir Mor, Ph.D., Professor, Biodesign Institute Center for Infectious Diseases and Vaccinology Cocaine addiction affects millions of people with disastrous personal and societal consequences. Cocaine is one of the most reinforcing of all drugs of abuse. Even those who undergo rehabilitation and experience long periods of abstinence have a more than 80 percent chance of relapse. Yet there is no FDA-approved treatment to decrease the likelihood of relapse in rehabilitated addicts. The...

Prominent scientists named to lead ASU Biodesign Institute Center for Infectious Diseases and Vaccinology

January 22, 2016

Charles Arntzen, a researcher who discovered a method for producing an Ebola treatment in a tobacco plant, and Cheryl Nickerson, a microbiologist who discovered that mechanical cues can globally reprogram how pathogens cause disease, have been named to lead the Biodesign Institute’s Center for Infectious Diseases and Vaccinology as interim co-directors. The Center for Infectious Diseases and Vaccinology, one of 15 research centers at the growing Biodesign Institute at Arizona State...

Arntzen named to National Academy of Inventors

December 23, 2015

Arizona State University Regents’ Professor and research scientist Charles Arntzen, Ph.D., has been named a Fellow of the National Academy of Inventors (NAI). Arntzen is a pioneer in plant biotechnology and the development of plant-based vaccines and therapeutics for human and animal disease prevention.  Referred to as “the godfather of pharming,” Arntzen is best known for playing a key role in developing ZMapp, the first successful treatment against the Ebola virus during the...